PROCASTAT

Welcome to the Brand page for “PROCASTAT”, which is offered here for Gene therapy products, pharmaceutical preparation vectors for use in gene therapy, clinical medical reagents, therapeutic compositions containing vectors for gene therapy for use in the treatment of cancer, neurological, ocular, hearing, balance and auto-immune disorders; enzymes and enzyme preparations for gene therapy purposes, retro viral vector and retro viral vector manufacturing preparations, all for the field of gene therapy, for the treatment of prostate cancer, with the exclusion of products intended for the treatment of cardiovascular diseases;color is not claimed as a feature of the mark.;instruments and apparatus for the administration of gene therapy products, vials, syringes, injectors, pumps, catheters, indwelling catheters and tubes; and surgical and medical apparatus and instruments, scalpels, knives, forceps and surgical clips; surgical instruments;.

Its status is currently believed to be active. Its class is unavailable. “PROCASTAT” is believed to be currently owned by “Oxford BioMedica plc”.